Concepedia

Yuval Naot

YN

3

Publications

112

Citations

3

H-Index

1999

Active since

Affiliations

Tennessee Oncology(Current)

Sarah Cannon

Yuval Naot is an author at Tennessee Oncology specializing in medicine, cell biology, and cancer therapeutics.

Top concepts

Publications per year

1999–2010

3

Publications

3

Paclitaxel/Carboplatin plus Bevacizumab/Erlotinib in the First-Line Treatment of Patients with Carcinoma of Unknown Primary Site

John D. Hainsworth, David R. Spigel, Dana S. Thompson et al. · The Oncologist · 2009 · 61 citations · Full text

Hematopoietic progenitor cell abnormalities in Hoxc-8 null mutant mice

Takashi Shimamoto, Yang Tang, Yuval Naot et al. · Journal of Experimental Zoology · 1999 · 31 citations

, , +11

A Phase II Trial of Dose-Dense Neoadjuvant Gemcitabine, Epirubicin, and Albumin-Bound Paclitaxel With Pegfilgrastim in the Treatment of Patients With Locally Advanced Breast Cancer

Denise A. Yardley, John D. Zubkus, Brooke Daniel et al. · Clinical Breast Cancer · 2010 · 20 citations

, , +8

Rows per page

1–3 of 3